These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9111865)

  • 1. Functional aspects of apoptosis in hematopoiesis and consequences of failure.
    McKenna SL; Cotter TG
    Adv Cancer Res; 1997; 71():121-64. PubMed ID: 9111865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in apoptosis genes: a pathogenetic factor for human disease.
    Müllauer L; Gruber P; Sebinger D; Buch J; Wohlfart S; Chott A
    Mutat Res; 2001 Jul; 488(3):211-31. PubMed ID: 11397650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of programmed cell death in normal and leukemic cells: new implications for therapy.
    Sachs L; Lotem J
    Blood; 1993 Jul; 82(1):15-21. PubMed ID: 8324219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
    Liebermann DA; Hoffman B
    Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
    Kobzdej M; Matuszyk J; Strzadala L
    Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes.
    Lotem J; Sachs L
    Leukemia; 1996 Jun; 10(6):925-31. PubMed ID: 8667646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis.
    Israels LG; Israels ED
    Stem Cells; 1999; 17(5):306-13. PubMed ID: 10527465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and the cell cycle.
    Fotedar R; Diederich L; Fotedar A
    Prog Cell Cycle Res; 1996; 2():147-63. PubMed ID: 9552392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
    Robertson MJ; Manley TJ; Pichert G; Cameron C; Cochran KJ; Levine H; Ritz J
    Leuk Lymphoma; 1995 Mar; 17(1-2):51-61. PubMed ID: 7539660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
    Rowan S; Ludwig RL; Haupt Y; Bates S; Lu X; Oren M; Vousden KH
    EMBO J; 1996 Feb; 15(4):827-38. PubMed ID: 8631304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
    Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The control of hematopoiesis and leukemia: from basic biology to the clinic.
    Sachs L
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4742-9. PubMed ID: 8643473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.
    Zhou M; Gu L; Yeager AM; Findley HW
    Leukemia; 1998 Nov; 12(11):1756-63. PubMed ID: 9823951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2.
    Martinez-Valdez H; Guret C; de Bouteiller O; Fugier I; Banchereau J; Liu YJ
    J Exp Med; 1996 Mar; 183(3):971-7. PubMed ID: 8642300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 proteins in development, health, and disease of the hematopoietic system.
    Kollek M; Müller A; Egle A; Erlacher M
    FEBS J; 2016 Aug; 283(15):2779-810. PubMed ID: 26881825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-colony stimulating factor induced apoptosis in radiation-induced murine leukemia cell line.
    Handa A; Kashimura T; Kawano N; Yamamoto A; Yoshida S; Jinnai I; Murohashi I; Bessho M; Hirashima K
    Leukemia; 1997 Apr; 11 Suppl 3():387-8. PubMed ID: 9209400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.
    Martin SJ; Reutelingsperger CP; McGahon AJ; Rader JA; van Schie RC; LaFace DM; Green DR
    J Exp Med; 1995 Nov; 182(5):1545-56. PubMed ID: 7595224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.
    Tsiftsoglou AS; Bonovolias ID; Tsiftsoglou SA
    Pharmacol Ther; 2009 Jun; 122(3):264-80. PubMed ID: 19306896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.
    Kikushige Y; Yoshimoto G; Miyamoto T; Iino T; Mori Y; Iwasaki H; Niiro H; Takenaka K; Nagafuji K; Harada M; Ishikawa F; Akashi K
    J Immunol; 2008 Jun; 180(11):7358-67. PubMed ID: 18490735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.